Global POCT market projected to reach US$36.83 billion by 2032

The global Point-of-Care Testing (POCT) products and devices market is projected to grow from approximately US$22.69 billion in 2025 to US$36.83 billion by 2032, representing a compound annual growth rate (CAGR) of roughly 7.27% between 2026 and 2032.

Driven by the shift from single-function tools to integrated clinical decision-making platforms, the market is expanding across various applications including emergency care, intensive care, primary care, and home-based chronic disease management. Key growth drivers include the rising global prevalence of diabetes—with the WHO reporting approximately 830 million patients in 2024—and an increasing demand for rapid testing in blood glucose, HbA1c, and infectious diseases.

Competition in the sector is characterized by high market concentration, with the top five companies accounting for approximately 73.47% of sales in 2022. Major players include Abbott, Roche, Danaher, Siemens Healthineers, and QuidelOrtho. The industry is transitioning from competing on reagent pricing to offering integrated solutions that combine devices, consumables, software, and clinical services.